NCT00507546View on ClinicalTrials.gov

Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

July 31, 2011

Conditions
InsomniaSpinal Cord InjuryTetraplegiaSleep Disorders
Interventions
DRUG

Ramelteon

8 mg nightly

DRUG

Placebo

Nightly 8mg of placebo (same appearance as ramelteon)

Trial Locations (1)

94304-1290

VA Palo Alto Health Care System, Palo Alto

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Stanford University

OTHER

collaborator

Takeda

INDUSTRY

lead

US Department of Veterans Affairs

FED

NCT00507546 - Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia | Biotech Hunter | Biotech Hunter